Cite
MLA Citation
Robert L Coleman et al.. “Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.” Lancet oncology, vol. 22, no. 5, 2021, pp. 609–619. http://access.bl.uk/ark:/81055/vdc_100129544568.0x000014